Product correctly added to cart.

discount label
3-Nitro-4-hydroxyquinoline
View 3D

Biosynth logo

3-Nitro-4-hydroxyquinoline

CAS: 50332-66-6

Ref. 3D-FN26264

2gTo inquire
5gTo inquire
10gTo inquire
25gTo inquire
50gTo inquire
Estimated delivery in United States, on Wednesday 17 Jul 2024

Product Information

Name:
3-Nitro-4-hydroxyquinoline
Synonyms:
  • 3-Nitro-quinolin-4-ol
  • 3-nitroquinolin-4(1H)-one
  • 3-Nitroquinolin-4-Ol
Description:

3-Nitro-4-hydroxyquinoline is a quinoline derivative that shows anticancer activity. It has been shown to inhibit the growth of human epidermal cells by inhibiting the proliferation of epidermal growth factor receptor (EGFR) and its downstream signaling pathways. 3-Nitro-4-hydroxyquinoline also inhibits HIV infection by binding to the viral envelope protein gp120, which prevents it from binding to or entering host cells. 3-Nitro-4-hydroxyquinoline is classified in cycle analysis as an industrial chemical. Its molecular modeling suggests that this drug binds to the mitochondrial membrane potential, enhancing 4-hydroxyquinoline's effects on cancer cell death.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
190.16 g/mol
Formula:
C9H6N2O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FN26264 3-Nitro-4-hydroxyquinoline

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".